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Leukocyte Transmigration in JAM-B Disrupted Mice
Takehisa Sakaguchi (Division of Developmental Biology, Research Center for Genomic Medicine, Saitama Medical 
School, 1397 -1, Yamane, Hidaka, Saitama 350 -1241, Japan)
　Junctional Adhesion Molecule (JAM)-B is known as one of the members of the immunoglobulin super family 
and is involved in formation of tight junction of many types of cells including epithelial and endothelial cells. It 
has recently been demonstrated that, in response to inflammation, JAM -B present on the surface of endothelial 
cell forms heterophilic interactions with JAM -C on the leukocyte during transmigration from blood vessels into 
affected tissues. The formation of JAM -B－JAM -C complex strongly suggests that this heterophilic interaction 
plays an important role in the transmigration of the leukocytes. To address this question, I generated mice lacking 
JAM-B. Subsequently, I examined leukocyte transmigration in JAM-B−/− mice by Contact Hyper Sensitivity (CHS) 
model using oxazolone as sensitizing agent and thioglycollate-induced peritonitis model. From these analyses, I 
found that levels of leukocyte transmigration in JAM-B−/− mice were similar to those of wild - type mice. Thus, our 
results established that the gene is dispensable for this event. 
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intercellular adhesion molecule (ICAM)-1との相互作用
を介して，白血球は血管壁上に強固に結合(Triggering 





























Endothelial (VE)-カドヘリン 16 -18)，そしてIgSFである





























































































































































白血球の懸濁液300 µlを500 x gで1分間遠心後，50 µl










の血液を採取した．そのうちの50 µlにFc blockerを1 
µl加え，室温で10分間静置した．次に，蛍光標識され
たCD45.2, CD4, CD8, Gr -1, Mac -1の 抗 体 を1 µl加 え
室温で30分間遮光して静置した．その後，1 x FACS 






















































Fig. 1. Targeting disruption of JAM-B gene. A, Top, genomic locus of JAM-B gene. Middle, targeting vector designed to insert 
an IRES-β-geo cassette into the JAM-B gene. Bottom, targeted locus. The 5’ and 3’ probes were located at the outside of the 
homologous regions present in the targeting vector, while the NEO probe was recovered from a portion of neomycin resistant 
gene. Restriction enzymes indicated were as follows: RI; EcoRI, Hd; HindIII, Sh; SphI, Sp; SpeI, RV; EcoRV. B, Southern blot 
hybridization analyses for genotyping of mice. Genomic DNA isolated from tail tips of mice were subjected to Southern blot 
analyses to determine genotype of mice. EcoRI, EcoRV, and SphI digested DNAs were hybridized to 5’, 3’, and Neo probes, 
respectively. Expected size of the genomic DNA fragments were as follows. 5’ probe: 20 kb for wild-type and 11.6 kb for targeted 
locus; 3’ probe: 14 kb for wild-type and 9.3 kb for targeted locus; Neo probe: none for wild-type and 8.6 kb for targeted locus. C, 
PCR for genotyping. PCR was performed for genotyping to obviate Southern blot analyses. Two sets of primers, which amplify 
the deleted region of JAM-B genomic locus (primers a and b) and a portion of neomycin gene (primer c and d), were added 
together in each reaction. Primer sets, a/b and c/d give 550 bp and 700 bp DNA fragments in reaction, respectively.
Wild-type	 Heterozygous	 Homozygous	 Total
51	（26.4％）	 93	（48.2％）	 49	（25.4％）	 193	(100％ )
Table 1. Analysis of JAM-B Heterozygous Intercross Progeny



















































Fig. 2. Normal distribution of cell population of peripheral 
white blood cells in JAM-B−/− mice. After preparation of 
mononuclear cells from peripheral bloods of wild-type and 
JAM-B-null mutant mice, cell populations were determined 
by fluorescence-activated cell sorting (FACS). Representative 
FACS profiles were shown which were obtained from CD45.2 
positive/propidium iodide negative population of the samples. 
Cells analyzed were as follows. Top panels, CD4/CD8 double-
positive and CD4 or CD8 single positive T cells. Middle 






HCT	（％）	 	 38.1±6	 38.7±0.9
MCV	（fl）	 	 54.7±2.3	 56.7±1.7
MCH	（pg）	 	 13.3±0.3	 14±0.3
MCHC	（g/dl）		 24.6±0.5	 24.7±0.3
Platelets	（104/μl）	 74.0±14.3	 65.2±5.4
Table 2. Hematopoietic Indices in Wild-type and JAM-B−/−















HGB, HCT, MCV, MCH等，血液成分に差異は見られ
Fig. 3. Normal response of JAM-B−/− mice to oxazolon-induced inflammation. A, Measurement of ear thickness of mice 
subjected to oxazolon-mediated inflammation. Wild-type and JAM-B−/− mice were applied to contact hypersensitivity model 
using oxazolon as an inducing reagent of inflammation. Thickness of control (right) and inflammation-induced (left) ears 
was measured using a dial gage. B, Histological analyses of inflammation-induced and non-induced ears of mice. Normal 
and inflammation-induced ears of wild-type and JAM-B-null mutant mice were used for histological analyses of hematoxylin-
eosin staining. Left two panels represent control ears, while right two panels represent inflammation-induced ears. C, 
Immunohistochemical analyses of T cells and granulocytes. Sections of inflammation-induced and non-induced ears of wild-
type and JAM-B−/− mice were subjected to immunohistochemistry using FITC-conjugated antibodies against CD3 and Gr-1 to 
monitor the levels of infiltrated T cells and granulocytes, respectively.

























































Fig. 4. Normal response of JAM-B−/−  mice to thioglycollate-
induced peritonitis. A, Comparison of amounts of leukocytes 
exuded into peritoneum cavity in response to thioglycollate-
induced inflammation. Numbers of cells were counted 
under the microscope. B, Cell populations of transmigrated 
leukocytes in peritoneum cavity. Cell populations of exuded 
granulocytes and monocytes were compared between wild-
type and JAM-B-null mutant mice by means of FACS. Cells 
analyzed were as follows. Top panel, no antibody control. 
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